ARCHIVES

Two Children Achieve Remission With CD19 Immunotherapy

This article is from The Cancer Letter archive.

Vol. 36 No. 3 | March 29, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Delays Decision On Avastin Approval For Breast Cancer

September 24, 2010

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

February 17, 2012

Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials.

October 15, 2004

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

January 29, 2010

FDA claims news coverage violated privacy of applicants for oncology job.

March 4, 2005

Telatinib Demonstrates Positive Results in First-Line Treatment

June 24, 2011